Liberty Biopharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 4

Liberty Biopharma General Information

Description

Developer of regenerative stem cell technologies and therapy solutions located in Richmond, Canada. The company engages in developing treatments for urogynecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, hepatic disease and kidney disease.

Contact Information

Website
www.libertybiopharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 8788 Mckim Way
  • Suite 2270
  • Richmond, British Columbia V6X 4E2
  • Canada
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Enlighta
Vertical(s)
Life Sciences
Corporate Office
  • 8788 Mckim Way
  • Suite 2270
  • Richmond, British Columbia V6X 4E2
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Liberty Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Liberty Biopharma‘s full profile, request access.

Request a free trial

Liberty Biopharma Acquisitions (4)

Liberty Biopharma’s most recent deal was a Reverse Merger with Enlighta. The deal was made on 01-Oct-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Enlighta 01-Oct-2018 Reverse Merger Other Healthcare Technology Systems
CTC Life Sciences 31-Aug-2018 Merger/Acquisition Other Healthcare Services
Cloud Medical Group 02-Jan-2018 Merger/Acquisition Enterprise Systems (Healthcare)
Avagenesis 03-Jan-2017 Merger/Acquisition Biotechnology
To view Liberty Biopharma’s complete acquisitions history, request access »

Liberty Biopharma Exits (1)

Liberty Biopharma’s most recent exit was on 01-Oct-2018 from Enlighta. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Enlighta 01-Oct-2018 Completed
To view Liberty Biopharma’s complete exits history, request access »

Liberty Biopharma FAQs

  • When was Liberty Biopharma founded?

    Liberty Biopharma was founded in 2010.

  • Where is Liberty Biopharma headquartered?

    Liberty Biopharma is headquartered in Richmond, Canada.

  • What industry is Liberty Biopharma in?

    Liberty Biopharma’s primary industry is Biotechnology.

  • Is Liberty Biopharma a private or public company?

    Liberty Biopharma is a Private company.

  • What is Liberty Biopharma’s current revenue?

    The current revenue for Liberty Biopharma is .

  • When was Liberty Biopharma acquired?

    Liberty Biopharma was acquired on 03-Oct-2018.

  • Who acquired Liberty Biopharma?

    Liberty Biopharma was acquired by Enlighta and Avapecia Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »